Close

Welcome back to Stockhouse
Member Sign In

Email or Username:
Password:
Close

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Enter your email address:
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Quote  |  Bullboard  |  News  |  Opinion  |  Level II  |  Charts  |  Profile  |  Financials  |  Options  |  Price History  |  Analysts  |  Earnings  |  Insiders

StemCells Inc STEM

Sector: Healthcare | Sub-Sector: Biotechnology

StemCells, Inc. is engaged in the research, development, and commercialization of stem cell therapeutics and related enabling technologies.
Price: $0.961 Volume: 558,268
Change: $-0.029 % Change: -2.90%
Day High/Low: 1.00/0.956 52 Week High/Low: 2.43/0.84
Last Traded: December 19, 2014 11:00 Transaction Volume: 18232
Open: 1.00 Previous Close: 0.99
Bid: Ask:
Bid Size: 0 Ask Size: 0
Market Cap: 66.1m Shares Out: 68.7m
PE Ratio: N/A Dividend Yield: N/A

Opinion

Make money from the next emerging boom

Surprising company keeps reinventing itself

Andrew Mickey   November 25, 2008
0 stars

Latest Bullboard Posts

  • Lot of ??? sent by the insiders and institutional

    0 stars

    If you noticed the unusual trading activities of the insiders and institutional holders most recently, "escaping" from this stock  may be...

    0 stars


  • RE: RE: Up and up

    0 stars

    Good to know this stock is moving for some reason not just Pump and Dump. I guess couple more good results can take this Stock up...

    2.5 stars


  • RE: Up and up

    0 stars

    Well, called that one right. Opened at 2.51 with high of 2.67.  Too bad it had to drop back down though. Next few months we should see it...

    1.5 stars


  • Do you think it will cross 4 ?

    0 stars

    As per one analyst it is suppose to go above 4...so do u also think it will ?

    2.5 stars


  • Up and up

    0 stars

    My prediction. $2.50 by Sept 5th. Then it will keep going.

    1.5 stars